Clinical Trials Browser

Unknown × Stomach Neoplasms × Doxorubicin × Clear all

NCT04358341 2020-08-24

Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms